Medical devices, healthcare technology and the business of care
510(k) clearance · K260058

Kerecis Express (50250)

Kerecis Limited · Decision date Oct 30, 2026

MEDTECHLEDGER EXPLANATIONK260058

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for Kerecis Express (50250), a wound dressing with animal-derived material, under 510(k) number K260058. The applicant is Kerecis Limited of Isafjordur, Iceland. The decision date is 10/30/2026 and the date received is 01/08/2026. The primary classification product code is KGN, with FRO listed as a subsequent product code, and the review panel is General & Plastic Surgery. A SESE decision is a 510(k) clearance, not a PMA approval.

The record describes a traditional 510(k) that was not reviewed by a third party, is not a combination product, and has no authorized predetermined change control plan. The specialty field is listed as unknown. The source does not include a summary statement, so the specific indications, materials, or performance data supporting the clearance are not established here and remain in the underlying FDA documents.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Unknown
Decision date
Oct 30, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260058
Regulatory pathway
510(k) premarket notification
Product code
KGN
Decision code
SESE
Decision date
Oct 30, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Wound Dressing With Animal-Derived Material(S).

Product code
KGN
FDA device class
U

FDA decision timeline

  1. K260058 received

    Application receipt date recorded by FDA.

  2. K260058 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code KGN

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Kerecis Limited

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Isafjordur

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records